News in brief: Sanofi off-loads drugs for bid

Merrill Lynch and BNP Paribas advised Sanofi-Synthélabo, the French pharmaceutical group, on the sale of two of its anti-thrombotic drugs as part of its assault to win Aventis, its Franco-German rival. European and US competition authorities ruled that it had to dispose of the drugs if its hostile €55.6bn ($67bn) bid for Aventis succeeded. GlaxoSmithKline, the world's largest pharmaceutical group, bought the drugs for €453m without the help of external financial advisers.

UBS hires Rushton from DrKW

WSJ Logo